Sample results
Non-malignant conditions are benign health issues that are not cancerous but may cause symptoms or require medical monitoring. They are caused by various factors including hormonal imbalances, inflammation, tissue overgrowth, or organ dysfunction that affect normal physiological processes. The CA 27.29 test is the most important marker for evaluating non-malignant conditions like benign breast disease, endometriosis, and liver disease.
Non-malignant conditions are caused by benign tissue changes, hormonal fluctuations, inflammatory processes, or organ dysfunction rather than cancerous cell growth. Common causes include hormonal imbalances like excess estrogen in endometriosis, inflammatory responses in conditions like benign breast disease, functional liver changes, or ovarian cysts that develop from normal ovulation processes. These conditions result from the body's natural physiological changes or responses to internal and external factors, creating symptoms that may mimic more serious diseases but lack the invasive characteristics of cancer.
The CA 27.29 test is the most important blood marker for evaluating non-malignant conditions because it detects elevated glycoprotein levels associated with benign breast disease, ovarian cysts, endometriosis, first trimester pregnancy, and liver disease. This marker helps healthcare providers distinguish between normal physiological changes and potentially concerning patterns by measuring mucin-like carcinoma-associated antigen levels in your blood. While CA 27.29 is often associated with cancer monitoring, its elevation in benign conditions provides valuable diagnostic information when interpreted alongside your medical history, physical examination findings, and imaging studies to guide appropriate treatment decisions.
You should get tested if you experience unexplained breast lumps or tenderness, persistent pelvic pain or irregular periods suggesting endometriosis, abnormal liver function symptoms like fatigue or jaundice, or if your doctor finds concerning changes during routine exams. Testing is especially important when symptoms persist despite initial treatments, when you have a family history of breast or ovarian conditions, or if imaging studies show abnormalities that need further clarification. Early testing helps establish baseline values and allows your healthcare provider to monitor changes over time, preventing unnecessary anxiety and guiding appropriate management strategies.
What this means
Your CA 27.29 level is slightly elevated above the normal reference range. While this may warrant further investigation, elevated levels can occur for several reasons beyond cancer recurrence, including benign breast conditions or other non-cancerous causes. It's important to discuss this result with your oncologist, who will consider it alongside your medical history, physical exam, and possibly imaging studies.
Recommended actions
Contact your oncologist to discuss these results and schedule any recommended follow-up tests
Keep a record of your CA 27.29 trend over time to monitor for changes
Continue maintaining a healthy lifestyle with balanced nutrition and regular exercise
Plan to retest in 4-8 weeks or as recommended by your healthcare provider
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: